Bioxel is a therapeutic design company focused on developing advanced peptides and proteins to target complex receptors and other important biological targets. Our approach uses the combined effects of different protein interactions to create specialized peptides that accurately control cell signals. This method improves treatment effectiveness and precision while reducing unwanted side effects, ultimately benefiting patients.
Company Details
- Founded
- -
- Address
- 1 Kendall Sq, Bldg 400
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://bioxel.net
- HQ
- Cambridge, Massachusetts
Bioxel, Inc. Questions
Bioxel, Inc.'s website is http://bioxel.net
Bioxel, Inc.'s LinkedIn profile is https://www.linkedin.com/company/bioxel-inc
Bioxel, Inc.'s industry is
Biotechnology Research
Bioxel, Inc.'s top competitors are
Peptifinder Biotech, Inc,
Maestro Therapeutics,
Bioxel,
Nextoar,
Psycora,
Bluestem Biosciences, Inc.,
Amide Technologies,
Psycora,
Peptide Drug Hunting Consortium,
Bioxel S.a..
Bioxel, Inc.'s categories are Biotechnology Research
Bioxel, Inc.'s founding year is 2023
